FDA Commissioner Marty Makary, M.D., has made his pick for the next director of the FDA’s Center for Drug Evaluation and Research (CDER) in veteran biotech executive George Tidmarsh, M.D., Ph.D.

I would also like to thank the Government of Fiji as hosts—Deputy Prime Minister Biman Prasad and I had a very productive exchange this morning. And to all Pacific leaders, and Finance and Economic ...

DALLAS – Researchers at the University of Texas at Dallas have created a portable food safety device they hope will one day be used at every level of the food industry – from processing ...

To the Editor: Prasad and Makary misrepresent international Covid-19 vaccination policies to justify restricting U.S. access to the vaccines.

Top-ranking Food and Drug Administration officials picked by the Trump administration under Health and Human Services Secretary Robert F. Kennedy Jr. overrode career staff at the agency to limit ...

Nicole Verdun, MD, super office director of the FDA’s Office of Therapeutic Products (OTP) and her deputy Rachael Anatol, PhD, have been placed on administrative leave. The moves led to a 31% ...

The FDA has reportedly put the director of its cell and gene therapy office on administrative leave and escorted her out of the agency.

Vinay Prasad is taking on several big roles at the FDA, solidifying his position as a top adviser to Commissioner Marty Makary.

By Bhartti Kumar IRVINE, CA — The ‘Diwali Fest’ organized by Ektaa Center on October 26 at the spacious Great Park amphitheater was a grand celebration of South Asian culture, drawing ...

Here's who the FDA says can get a new COVID-19 vaccine this fall amid a change in policy The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for ...

Health experts say there are legitimate questions about how much everyone still benefits from yearly COVID vaccination or whether they should be recommended only for people at increased risk.

The U.S. Food and Drug Administration on Tuesday said it plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under age 65, effectively limiting them ...